China Isotope & Radiation Corp

Detailed Description

China Isotope & Radiation Corporation engages in the research and development, manufacture, and sale of diagnostic and therapeutic radiopharmaceuticals and radioactive source products for medical and industrial applications in China. It operates through four segments: Pharmaceuticals, Radioactive Source Products, Irradiation, and Independent Clinical Laboratory Services and Other Businesses. The company's Pharmaceuticals segment engages in the research, development, manufacture, and sale of imaging diagnostic and therapeutic radiopharmaceuticals; UBT kits and analyzers; and in vitro immunoassay diagnostic reagents and kits. Its Radioactive Source Products segment provides medical and industrial radioactive sources products and related technical services. The company's Irradiation segment offers irradiation service to manufacturers of medical devices, food, traditional Chinese medicine, and cosmetics for sterilization; and EPC services for the design, manufacturing, and installation of gamma ray irradiation facilities to irradiation service providers. Its Independent Clinical Laboratory Services and Other Businesses segment provides independent clinical laboratory services with respect to hepatitis, endocrine, bone metabolism, cardiovascular disease, diabetes, and other diseases to hospitals and other medical institutions. As of December 31, 2019, the company's sales network included 11,000 hospitals and other medical institutions, such as 1,800 tertiary hospitals, 5,000 secondary hospitals, and 4,400 primary hospitals in China. The company was founded in 1983 and is headquartered in Beijing, China. China Isotope & Radiation Corporation is a subsidiary of China National Nuclear Corporation.